| Bryant Hayes, DPT | |
|
700 2nd St Ne, Washington, DC 20002 | |
| (202) 346-3000 | |
| Not Available |
| Full Name | Bryant Hayes |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 700 2nd St Ne, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164874996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 26037 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Medicaid spending increased to $276 billion by fiscal year (FY)2003, up one-third from FY2000, according to a new web-exclusive article released today by the peer-reviewed journal Health Affairs and commissioned by the Kaiser Commission on Medicaid and the Uninsured.
Science is collaborative by nature, since scientific knowledge only advances, step by step, through combined efforts and findings. Nevertheless, there is often a lack of communication regarding the more technical and everyday advances in laboratory work, and as a result research progresses less quickly.
There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin"). This path involves the B-cell of the immune system, so far only considered "innocent spectators," as Catholic University rheumatologist Gianfranco Ferraccioli, among the authors of the important research, puts it.
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.
Kaiser Health News: On Sept. 23, a number of health law provisions will go into effect, including a ban on lifetime caps on health benefits, a practice some insurance plans use to restrain costs. For one family with two children with hemophilia whose treatments cost around $250,000 a year, that's a reassuring change that means "more freedom" for the kids.
› Verified 1 days ago
| Provider Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Medicaid spending increased to $276 billion by fiscal year (FY)2003, up one-third from FY2000, according to a new web-exclusive article released today by the peer-reviewed journal Health Affairs and commissioned by the Kaiser Commission on Medicaid and the Uninsured.
Science is collaborative by nature, since scientific knowledge only advances, step by step, through combined efforts and findings. Nevertheless, there is often a lack of communication regarding the more technical and everyday advances in laboratory work, and as a result research progresses less quickly.
There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin"). This path involves the B-cell of the immune system, so far only considered "innocent spectators," as Catholic University rheumatologist Gianfranco Ferraccioli, among the authors of the important research, puts it.
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.
Kaiser Health News: On Sept. 23, a number of health law provisions will go into effect, including a ban on lifetime caps on health benefits, a practice some insurance plans use to restrain costs. For one family with two children with hemophilia whose treatments cost around $250,000 a year, that's a reassuring change that means "more freedom" for the kids.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryant Hayes, DPT 7921 Maryknoll Ave, Bethesda, MD 20817-2924 Ph: (240) 672-8177 | Bryant Hayes, DPT 700 2nd St Ne, Washington, DC 20002 Ph: (202) 346-3000 |
News Archive
Medicaid spending increased to $276 billion by fiscal year (FY)2003, up one-third from FY2000, according to a new web-exclusive article released today by the peer-reviewed journal Health Affairs and commissioned by the Kaiser Commission on Medicaid and the Uninsured.
Science is collaborative by nature, since scientific knowledge only advances, step by step, through combined efforts and findings. Nevertheless, there is often a lack of communication regarding the more technical and everyday advances in laboratory work, and as a result research progresses less quickly.
There is a new path to defeat systemic sclerosis, also called scleroderma because of the hardening of the skin of the patients (from Greek skleros, "hard", and derma, "skin"). This path involves the B-cell of the immune system, so far only considered "innocent spectators," as Catholic University rheumatologist Gianfranco Ferraccioli, among the authors of the important research, puts it.
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.
Kaiser Health News: On Sept. 23, a number of health law provisions will go into effect, including a ban on lifetime caps on health benefits, a practice some insurance plans use to restrain costs. For one family with two children with hemophilia whose treatments cost around $250,000 a year, that's a reassuring change that means "more freedom" for the kids.
› Verified 1 days ago
Jeffrey Adam Miller, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1001 G St Nw, Washington, DC 20001 Phone: 202-347-7745 Fax: 202-347-7747 | |
Tyler Allee, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1705 Desales St Nw, 6th Floor, Washington, DC 20036 Phone: 202-630-0378 | |
Bettie R Kruger, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 600 Pennsylvania Ave Se, Suite 202, Washington, DC 20003 Phone: 202-543-9400 | |
Erin Foley, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Defense St Pentagon, Washington, DC 20310 Phone: 037-692-8982 | |
Triumph Pediatric Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4900 Massachusetts Ave Nw # 340, Washington, DC 20016 Phone: 240-336-4976 | |
Vuong Duc Tran, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2021 K St Nw Ste 215, Washington, DC 20006 Phone: 240-898-4446 | |
Mr. Courtland Wyatt, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3700 N Capitol St Nw, Washington, DC 20011 Phone: 800-422-9988 Fax: 301-262-1259 |